Angiodynamics (ANGO) Non Operating Income (2015 - 2026)
Angiodynamics' (ANGO) quarterly Non Operating Income came in at -$4.8 million in Q2 2026, up 9.49% YoY from -$4.4 million in Q2 2025, and down 197.68% on a QoQ basis from $4.9 million in Q1 2026.
Angiodynamics (ANGO) Non Operating Income (2015 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 12 years of Non Operating Income data on file, last reported at -$4.8 million in Q2 2026.
- Quarterly Non Operating Income rose 9.49% year-over-year to -$4.8 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$121000.0 (down 112.37% YoY) and the FY2026 annual result came in at -$299000.0, down 130.57% from the prior year.
- Non Operating Income declined to -$4.8 million in Q2 2026, from $4.9 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $5.6 million in Q1 2025 to a low of -$5.3 million in Q2 2025.
- A 5-year average of -$54722.2 and a median of -$199500.0 in 2023 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 3467.31% in 2025, down 568.09% in 2025.
- Tracing ANGO's Non Operating Income over 5 years: stood at -$936000.0 in 2022, then surged by 157.05% to $534000.0 in 2023, then tumbled by 53.93% to $246000.0 in 2024, then slumped by 193.5% to -$230000.0 in 2025, then tumbled by 1972.17% to -$4.8 million in 2026.
- The last three Non Operating Income figures came in at -$4.8 million (Q2 2026), $4.9 million (Q1 2026), and -$230000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.55 Bn | 129.33 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.55 Bn | 51.69 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.72 Bn | 34.36 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.85 Bn | 32.38 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.10 Bn | 26.42 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.82 Bn | 14.69 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | - |
| 10 | Angiodynamics | 649.47 Mn | 595.60 Mn | 46.77 Mn | -840,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -4.77 Mn |
| Feb 28, 2026 | 4.88 Mn |
| Nov 30, 2025 | -230,000.00 |
| Aug 31, 2025 | -4,000.00 |
| May 31, 2025 | -5.27 Mn |
| Feb 28, 2025 | 5.57 Mn |
| Nov 30, 2024 | 246,000.00 |
| Aug 31, 2024 | 433,000.00 |
| May 31, 2024 | 1.13 Mn |
| Feb 29, 2024 | 156,000.00 |
| Nov 30, 2023 | 534,000.00 |
| Aug 31, 2023 | -169,000.00 |
| May 31, 2023 | -474,000.00 |
| Feb 28, 2023 | -736,000.00 |
| Nov 30, 2022 | -936,000.00 |
| Aug 31, 2022 | -556,000.00 |
| May 31, 2022 | -324,000.00 |
| Feb 28, 2022 | -462,000.00 |
| Nov 30, 2021 | -184,000.00 |
| Aug 31, 2021 | -508,000.00 |